351 related articles for article (PubMed ID: 25746020)
1. Association of inflammatory and hemostatic markers with stroke and thromboembolic events in atrial fibrillation: a systematic review and meta-analysis.
Wu N; Chen X; Cai T; Wu L; Xiang Y; Zhang M; Li Y; Song Z; Zhong L
Can J Cardiol; 2015 Mar; 31(3):278-86. PubMed ID: 25746020
[TBL] [Abstract][Full Text] [Related]
2. Association of hemostatic markers with atrial fibrillation: a meta-analysis and meta-regression.
Wu N; Tong S; Xiang Y; Wu L; Xu B; Zhang Y; Ma X; Li Y; Song Z; Zhong L
PLoS One; 2015; 10(4):e0124716. PubMed ID: 25884835
[TBL] [Abstract][Full Text] [Related]
3. Predictive Role of Coagulation, Fibrinolytic, and Endothelial Markers in Patients with Atrial Fibrillation, Stroke, and Thromboembolism: A Meta-Analysis, Meta-Regression, and Systematic Review.
Weymann A; Sabashnikov A; Ali-Hasan-Al-Saegh S; Popov AF; Jalil Mirhosseini S; Baker WL; Lotfaliani M; Liu T; Dehghan H; Yavuz S; de Oliveira Sá MP; Jang JS; Zeriouh M; Meng L; D'Ascenzo F; Deshmukh AJ; Biondi-Zoccai G; Dohmen PM; Calkins H; Cardiac Surgery And Cardiology-Group Imcsc-Group IM
Med Sci Monit Basic Res; 2017 Mar; 23():97-140. PubMed ID: 28360407
[TBL] [Abstract][Full Text] [Related]
4. Plasma von Willebrand factor levels are an independent risk factor for adverse events including mortality and major bleeding in anticoagulated atrial fibrillation patients.
Roldán V; Marín F; Muiña B; Torregrosa JM; Hernández-Romero D; Valdés M; Vicente V; Lip GY
J Am Coll Cardiol; 2011 Jun; 57(25):2496-504. PubMed ID: 21497043
[TBL] [Abstract][Full Text] [Related]
5. Effects of fixed low-dose warfarin, aspirin-warfarin combination therapy, and dose-adjusted warfarin on thrombogenesis in chronic atrial fibrillation.
Li-Saw-Hee FL; Blann AD; Lip GY
Stroke; 2000 Apr; 31(4):828-33. PubMed ID: 10753983
[TBL] [Abstract][Full Text] [Related]
6. Intracardiac Hemostasis and Fibrinolysis Parameters in Patients with Atrial Fibrillation.
Tóth NK; Csanádi Z; Hajas O; Kiss A; Nagy-Baló E; Kovács KB; Sarkady F; Muszbek L; Bereczky Z; Csiba L; Bagoly Z
Biomed Res Int; 2017; 2017():3678017. PubMed ID: 28713823
[TBL] [Abstract][Full Text] [Related]
7. Detection of a hypercoagulable state in nonvalvular atrial fibrillation and the effect of anticoagulant therapy.
Mitusch R; Siemens HJ; Garbe M; Wagner T; Sheikhzadeh A; Diederich KW
Thromb Haemost; 1996 Feb; 75(2):219-23. PubMed ID: 8815563
[TBL] [Abstract][Full Text] [Related]
8. High D-dimer levels predict cardiovascular events in patients with chronic atrial fibrillation during oral anticoagulant therapy.
Vene N; Mavri A; Kosmelj K; Stegnar M
Thromb Haemost; 2003 Dec; 90(6):1163-72. PubMed ID: 14652652
[TBL] [Abstract][Full Text] [Related]
9. Activation of the endogenous coagulation system in patients with atrial flutter: relationship to echocardiographic markers of thromboembolic risk.
Kamath GS; Herweg B; Cotiga D; Pierce W; Cohen AJ; Chaudhry FA; Drejka ML; Steinberg JS
Cardiol J; 2010; 17(4):390-6. PubMed ID: 20690096
[TBL] [Abstract][Full Text] [Related]
10. Stroke or left atrial thrombus prediction using antithrombin III and mean platelet volume in patients with nonvalvular atrial fibrillation.
Choi SW; Kim BB; Choi DH; Park G; Shin BC; Song H; Kim D; Kim DM
Clin Cardiol; 2017 Nov; 40(11):1013-1019. PubMed ID: 28805957
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-6 and C-reactive protein and risk for death and cardiovascular events in patients with atrial fibrillation.
Aulin J; Siegbahn A; Hijazi Z; Ezekowitz MD; Andersson U; Connolly SJ; Huber K; Reilly PA; Wallentin L; Oldgren J
Am Heart J; 2015 Dec; 170(6):1151-60. PubMed ID: 26678637
[TBL] [Abstract][Full Text] [Related]
12. D-dimer level influences thromboembolic events in patients with atrial fibrillation.
Nozawa T; Inoue H; Hirai T; Iwasa A; Okumura K; Lee JD; Shimizu A; Hayano M; Yano K
Int J Cardiol; 2006 Apr; 109(1):59-65. PubMed ID: 15992948
[TBL] [Abstract][Full Text] [Related]
13. Effect of hyperthyroidism on the hypercoagulable state and thromboembolic events in patients with atrial fibrillation.
Chen Q; Yan Y; Zhang L; Cheng K; Liu Y; Zhu W
Cardiology; 2014; 127(3):176-82. PubMed ID: 24434544
[TBL] [Abstract][Full Text] [Related]
14. Evidence that D-dimer levels predict subsequent thromboembolic and cardiovascular events in patients with atrial fibrillation during oral anticoagulant therapy.
Sadanaga T; Sadanaga M; Ogawa S
J Am Coll Cardiol; 2010 May; 55(20):2225-31. PubMed ID: 20466203
[TBL] [Abstract][Full Text] [Related]
15. D-dimer levels in combination with clinical risk factors can effectively predict subsequent thromboembolic events in patients with atrial fibrillation during oral anticoagulant therapy.
Sadanaga T; Kohsaka S; Ogawa S
Cardiology; 2010; 117(1):31-6. PubMed ID: 20881392
[TBL] [Abstract][Full Text] [Related]
16. Hemostatic state and atrial fibrillation (the Framingham Offspring Study).
Feng D; D'Agostino RB; Silbershatz H; Lipinska I; Massaro J; Levy D; Benjamin EJ; Wolf PA; Tofler GH
Am J Cardiol; 2001 Jan; 87(2):168-71. PubMed ID: 11152833
[TBL] [Abstract][Full Text] [Related]
17. Prognostic role of plasma von Willebrand factor and soluble E-selectin levels for future cardiovascular events in a 'real-world' community cohort of patients with atrial fibrillation.
Krishnamoorthy S; Khoo CW; Lim HS; Lane DA; Pignatelli P; Basili S; Violi F; Lip GY
Eur J Clin Invest; 2013 Oct; 43(10):1032-8. PubMed ID: 23961715
[TBL] [Abstract][Full Text] [Related]
18. Thromboembolic events are associated with prolonged clot lysis time in patients with permanent atrial fibrillation.
Ząbczyk M; Majewski J; Lelakowski J
Pol Arch Med Wewn; 2011 Nov; 121(11):400-7. PubMed ID: 22064373
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory Biomarkers and Atrial Fibrillation: Potential Role of Inflammatory Pathways in the Pathogenesis of Atrial Fibrillation-induced Thromboembolism.
Guo Y; Lip GY; Apostolakis S
Curr Vasc Pharmacol; 2015; 13(2):192-201. PubMed ID: 24188486
[TBL] [Abstract][Full Text] [Related]
20. Blood Biomarkers of Heart Failure and Hypercoagulation to Identify Atrial Fibrillation-Related Stroke.
Kneihsl M; Gattringer T; Bisping E; Scherr D; Raggam R; Mangge H; Enzinger C; Fandler-Höfler S; Eppinger S; Hermetter C; Bucnik B; Poltrum B; Niederkorn K; Fazekas F
Stroke; 2019 Aug; 50(8):2223-2226. PubMed ID: 31216968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
